FeesSafety
Pluang+

Grayscale lets investors swap XRP, Solana, Dogecoin directly for fund shares with high minimums.

Market News
22 Oct 2026
Coinpaper
View Source
Bullish
Grayscale lets investors swap XRP, Solana, Dogecoin directly for fund shares with high minimums.

Grayscale has expanded its platform to allow eligible investors to exchange cryptocurrencies like XRP, Solana, and Dogecoin directly for shares in ten of its funds, bypassing the need to convert tokens to cash first. Minimum contributions range from about $80,300 for Solana to $364,800 for Bitcoin. This move simplifies the process for large crypto holders to invest through traditional brokerage accounts and may reduce operational costs. However, it does not guarantee increased demand or token price rises, as fund shares can trade at premiums or discounts and tax implications remain.

Grayscale's new option for exchanging cryptocurrencies like XRP, Solana, and Dogecoin for fund shares is the subject here. For readers following major cryptocurrencies, here is Pluang's market snapshot as of Oct 22, 2026 23:51 WIB: out of 50 priced major cryptocurrencies, 4 rose and 45 fell today. Notable moves include ALGO at Rp1.922 with a -7.24% change, LINK at Rp212.969 with a -7.09% change, and MANA at Rp1.488 with a -6.83% change.

More News

Dayton T. Brown opens new Huntsville Test & Qualification Center to boost aerospace and defense testing.

Dayton T. Brown opens new Huntsville Test & Qualification Center to boost aerospace and defense testing.

Dayton T. Brown, Inc. inaugurated its new 104,000-square-foot Test & Qualification Center in Huntsville, Alabama, enhancing its capacity to support aerospace, defense, and propulsion programs. The facility's strategic location near Huntsville's aeros...

Market News
Bullish
36 minutes ago
60% of CCOs say communications functions lag behind their leadership roles, needing better systems and resources.

60% of CCOs say communications functions lag behind their leadership roles, needing better systems and resources.

A new study by The Grossman Group reveals that while 60% of chief communications officers (CCOs) have influence at the leadership level, their communications functions lack the necessary systems, skills, and AI capabilities to fully meet their mandat...

Others
Neutral
36 minutes ago
Over 200 companies advance 240+ Alzheimer's drugs, marking a new phase in treatment development

Over 200 companies advance 240+ Alzheimer's drugs, marking a new phase in treatment development

More than 200 companies are actively developing over 240 Alzheimer's disease therapies, with around 20 drugs in late-stage trials and many others in earlier phases. Key players include Eli Lilly, Biogen, Johnson & Johnson, and Eisai, focusing on inno...

Market News
Bullish
36 minutes ago
Sagimet Biosciences starts key Phase 3 trial for acne drug denifanstat in the U.S.

Sagimet Biosciences starts key Phase 3 trial for acne drug denifanstat in the U.S.

Sagimet Biosciences has initiated a crucial Phase 3 clinical trial in the U.S. for denifanstat, an oral treatment targeting moderate to severe acne. The trial, named AURORA, aims to enroll around 800 patients, including adolescents, to support regula...

Market News
Bullish
1 hour ago
Nokia beats Q3 earnings and revenue estimates with strong AI and cloud sales growth.

Nokia beats Q3 earnings and revenue estimates with strong AI and cloud sales growth.

Nokia reported third-quarter 2026 earnings per share of $0.10, surpassing the $0.08 estimate, and revenue of $5.78 billion, exceeding the $5.72 billion forecast. The company's AI and cloud sales surged 123%, driven by high demand for its IP Networks ...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App